'Vasculitis look-alike' clinical syndromes

Journal of Clinical Rheumatology

Volumn 2, Issue 4, 1996, Pages 203-208

  Staud, Roland ^a   Bruce Yancey Jr , W ^a   Williams Jr , Ralph C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Fibromuscular dysplasia; Necrotizing vasculitis; Pseudovasculitis

Indexed keywords

CHOLESTEROL; CORTICOSTEROID; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY;

ADULT; AMYLOIDOSIS; ANTIPHOSPHOLIPID SYNDROME; AORTA COARCTATION; ARTICLE; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; EMBOLISM; FIBROMUSCULAR DYSPLASIA; HEART MYXOMA; HUMAN; MALE; NECROTIZING ARTERITIS; NEUROFIBROMATOSIS; PRIORITY JOURNAL; VASCULITIS;

EID: 9444282611     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199608000-00008     Document Type: Article

References (74)

1. Lie JT. Cholesterol atheromatous embolism. The great masquerader revisited. Pathol Annu 1992;27:17-50.
2. Kassirer JP. Atheroembolic renal disease. N Engl J Med 1969;280:812-818.
3. Smith MC, Ghose MK, Henry AR. The clinical spectrum of renal cholesterol embolization. Am J Med 1981;71:174-180.
4. Antonucci F, Pizzolitto S, Travaglini M, et al. Atheroembolic renal disease: clinico-pathologic correlations. Adv Exp Med Biol 1989;252: 59-64.
5. Carvajal JA, Anderson WR, Weiss L, Grismer J, Berman R. Atheroembolism. An etiologic factor in renal insufficiency, gastrointestinal hemorrhages, and peripheral vascular diseases. Arch Intern Med 1967;119:593-599.
6. Gore I, Collins DP. Spontaneous atheromatous embolization. Review of the literature and a report of 16 additional cases. Am J Clin Pathol 1960;3:416-426.
7. Anderson WR, Richards AM. Evaluation of lower extremity muscle biopsies in the diagnosis of atheroembolism. Arch Pathol 1968;86: 535-541.
8. Anderson WR, Braverman T. Colon perforation due to cholesterol embolism. Hum Pathol 1991;22:839-841.
9. Richards AM, Eliot RS, Kanjuh VI, Bloemendaal RD, Edwards JE. Cholesterol embolism: a multiple-system disease masquerading as polyarterios nodosa. Am J Cardiol 1965;15:696-707.
10. Young DK, Burton MF, Herman JH. Multiple cholesterol emboli syndrome simulating sytemic necrotizing vasculitis. J Rheumatol 1986; 13:423-426.
11. Cappiello RA, Espinosa LR, Adelman H, Aguilar J, Vasey FB, Germain BF. Cholesterol embolism: a pseudovasculitic syndrome. Semin Arthritis Rheum 1989;240:246.
12. Jeynes BJ, Warren BA. Thrombogenicity of components of atheromatous material. An animal and in vitro model of cerebral atheroembolism. Arch Pathol Lab Med 1981;105:353-357.
13. Eliot RS, Kanjuh VI, Edwards JE. Atheromatous embolism. Circulation 1964;30:611-618.
14. Rosansky SJ, Deschamps EG. Multiple cholesterol emboli syndrome after angiography. Am J Med Sci 1984;288:45-48.
15. Thurlbeck WM, Castleman B. Atheromatous emboli to the kidneys after aortic surgery. N Engl J Med 1957;257:442-447.
16. Harrington JT, Sommers SC, Kassirer JP. Atheromatous emboli with progressive renal failure. Renal arteriography as the probable inciting factor. Ann Intern Med 1968;68:152-160.
17. Cosio F, Zager RA, Sharma HM. Atheroembolic renal disease causes hypocomplementaemia. Lancet 1985;2:118-121.
18. Cogan E, Schandene L, Papadopoulos T, Crusiaux A, Goldman M. Interleukin-5 production by T lymphocytes in atheroembolic disease with hypereosinophilia. J Allergy Clin Immunol 1995;96:427-429.
19. Lye WC, Cheah JS, Sinniah R. Renal cholesterol embolic disease. Case report and review of the literature. Am J Nephrol 1993;13:489-493.
20. Wilson DM, Salazer TL, Farkouh ME. Eosinophiluria in atheroembolic renal disease. Am J Med 1991;91:186-189.
21. David NJ, Klintworth GK, Friedberg SJ, Dillon M. Fatal atheromatous cerebral embolism associated with bright plaques in the retinal arterioles: report of a case. Neurology 1963;13: 708-713.
22. Pribram HFW, Couver CM. Retinal embolism as complication of angiography: the possible role of platelet and cholesterol emboli. Neurology 1965;15:188-190.
23. Hollenhorst RW. Significance of bright plaques in the retinal arterioles. JAMA 1961; 178:23-29.
24. Rodriguez Sanchez C, Medina Sanchez M, Malik RA, Ah See AK, Sharma AK. Morphological abnormalities in the sural nerve from patients with peripheral vascular disease. Histol Histopathol 1991;6:63-71.
25. Reynen K. Cardiac myxomas. N Engl J Med 1995;33:1610-1617.
26. Zitnik RS, Giuliani ER. Clinical recognition of atrial myxoma. Am Heart J 1970;80:689-700.
27. Goodwin JF. The spectrum of cardiac tumors. Am J Cardiol 1968;21:307-314.
28. MacGregor GA, Cullen RA. The syndrome of fever, anaemia, and high sedimentation rate with an atrial myxoma. Br Med J 1959;2:991-993.
29. Yufe R, Karpati G, Carpenter S. Cardiac myxoma: a diagnostic challenge for the neurologist. Neurology 1976;26:1060-1065.
30. McWhirter WR, Tetteh Lartey EV. A case of atrial myxoma. Br Heart J 1974;6:839-840.
31. Yarnell PR, Spann JFJ, Dougherty J, Mason DT. Episodic central nervous system ischemia of undetermined cause: relation to occult left atrial myxoma. Stroke 1971;2:35-40.
32. Huston KA, Combs Jr JJ, Lie JT, Giuliani ER. Left atrial myxoma simulating peripheral vasculitis. Mayo Clin Proc 1978;53:752-756.
33. Leonhardt ET, Kullenberg KP. Bilateral atrial myxomas with multiple arterial aneurysms. A syndrome mimicking polyarteritis nodosa. Am J Med 1977;62:792-794.
34. Burton C, Johnston J. Multiple cerebral aneurysms and cardiac myxoma. N Engl J Med 1970;282:35-36.
35. Thomas MH. Myxomas masquerading as polyarteritis nodosa. J Rheumatol 1981;8:133-137.
36. Stoane L, Allen JHJ, Collins HA. Radiologic observations in cerebral embolization from left heart myxomas. Radiology 1966;87:262-266.
37. Price DL, Harris JL, New PF, Cantu RC. Cardiac myxoma. A clinopathologic and angiographic study. Arch Neurol 1970;23:558-567.
38. Boussen K, Moalla M, Blondeau P, Ben Ayed H, Lie JT. Embolization of cardiac myxomas masquerading as polyarteritis nodosa. J Rheumatol 1991;18:283-285.
39. Luscher TF, Keller HM, Imhof HG, et al. Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron 1986; 44(Suppl 1):109-114.
40. Luscher TF, Lie JT, Stanson AW, Houser OW, Hollier LH, Sheps SG. Arterial fibromuscular dysplasia. Mayo Clin Proc 1987;62:931-952.
41. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med 1980;140:233-236.
42. Stewart BH, Dustan HP, Kiser WS, Meaney TF, Straffon RA, McCormack LJ. Correlation of angiography and natural history in evaluation of patients with renovascular hypertension. J Urol 1970;104:231-238.
43. Meyers DS, Grim CE, Keitzer WF. Fibromuscular dysplasia of the renal artery with medial dissection. Am J Med 1974;56:412-416.
44. Pilz P, Hartjes HJ. Fibromuscular dysplasia and multiple dissecting aneurysms of intracranial arteries. A further cause of Moyamoya syndrome. Stroke 1976;7:393-398.
45. den Butter G, van Bockel JH, Aarts JC. Arterial fibrodysplasia: rapid progression complicated by rupture of a visceral aneurysm into the gastrointestinal tract. J Vasc Surg 1988;7:449-453.
46. Mandreoli M, Zuccala A, Zucchelli P. Fibromuscular dysplasia of the renal arteries associated with antiphospholipid autoantibodies: two case reports. Am J Kidney Dis 1992;20: 500-503.
47. Gatalica Z, Gibas Z, Martinez Hernandez A. Dissecting aortic aneurysm as a complication of generalized fibromuscular dysplasia. Hum Pathol 1992;23:586-588.
48. Meire FM, De Laey JJ, Van Thienen MN, Schuddinck L. Retinal manifestations in fibromuscular dysplasia. Eur J Ophthalmol 1991;1: 63-68.
49. Lieber E. Galen on contaminated cereals as a cause of epidemics. Bull Hist Med 1970;44: 332-345.
50. Henry GG, Blackwood JS, Conley JE, Bernhard VM. Ergotism. Arch Surg 1975;110:929-932.
51. Hauck AJ, Edwards WD, Danielson GK, Mullany CJ, Bresnahan DR. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature. Arch Pathol Lab Med 1990; 114:62-64.
52. Horowitz RS, Dart RC, Gomez HF. Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction. Arch Intern Med 1996;156:456-458.
53. Liao JK, Cockrill BA, Yurchak PM. Acute myocardial infarction after ergonovine administration for uterine bleeding. Am J Cardiol 1991;68:823-824.
54. Goldfischer JD. Acute myocardial infarction secondary to ergot therapy. N Engl J Med 1960;262:860-863.
55. Greene FL, Ariyan S, Stansel HCJ. Mesenteric and peripheral vascular ischemia secondary to ergotism. Surgery 1977;81:176-179.
56. Salyer WR, Salyer DC. The vascular lesions of neurofibromatosis. Angiology 1974;25:510-519.
57. DiPrete DA, Abuelo JG, Abuelo DN, Cronan JJ. Acute renal insufficiency due to renal infarctions in a patient with neurofibromatosis. Am J Kidney Dis 1990;15:357-360.
58. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990;112:682-698.
59. Lie JT. Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both? J Rheumatol 1989;16:713-715.
60. Lie JT. Vasculitis in the antiphospholipid syndrome: culprit or consort? J Rheumatol 1994; 21:397-399.
61. Lie JT. The distinction between vasculitis coincidental with and one that is causally related to the antiphospholipid syndrome. Arthritis Rheum 1992;35:1540.
62. Pope JM, Canny CL, Bell DA. Cerebral ischemie events associated with endocarditis, retinal vascular disease, and lupus anticoagulant. Am J Med 1991;90:299-309.
63. Ginsburg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992;117:997-1002.
64. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2 glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci U S A 1990;87:4120-4124.
65. De Groot PG, Derksen RH. Protein C pathway, antiphospholipid antibodies and thrombosis. Lupus 1994;3:229-233.
66. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19:508-512.
67. Rao JK, Allen NB. Primary systemic amyloidosis masquerading as giant scell arteritis. Arthritis Rheum 1993;36:422-425.
68. Wiik A. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis. Clin Exp Rheumatol 1993;11:191-201.
69. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunogenetic and pathogenetic aspects. Clin Exp Immunol 1993; 91:1-12.
70. Jennings JG, Chang L, Savige JA. Anti-proteinase 3 antibodies, their characterization and disease associations. Clin Exp Immunol 1994; 95:251-256.
71. Coremans IEM, Hagen EC, Van der Voort EAM, Van der Woude FJ, Daha MR, Breedveld FC. Autoantibodies to neutrophil cytoplasmic enzymes in Felty's syndrome. Clin Exp Rheumatol 1993;11:255-262.
72. Snook JA, Chapman RW, Fleming K, Jewell DP. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1989;76:30-33.
73. Mulder AH, Horst G, Van Leeuwen MA, Limburg PC, Kallenberg CG. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations. Arthritis Rheum 1993;36:1054-1060.
74. Dolman KM, Gans ROB, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993;342:651-652.